Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy

Observational/retrospective studies indicate that prostaglandin-endoperoxide synthase-2 (PTGS2) inhibitors could positively affect colorectal cancer (CRC) patients’ survival after diagnosis. To obtain an acceptable cost/benefit balance, the inclusion of PTGS2 inhibitors in the adjuvant setting...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Roberta Venè, Delfina Costa, Raffaella Augugliaro, Sebastiano Carlone, Stefano Scabini, Gianmaria Casoni Pattacini, Maurizio Boggio, Simonetta Zupo, Federica Grillo, Luca Mastracci, Francesca Pitto, Simona Minghelli, Nicoletta Ferrari, Francesca Tosetti, Emanuele Romairone, Maria C. Mingari, Alessandro Poggi, Roberto Benelli
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2020-03-01
Seri Bilgileri:	Cells
Konular:	prostaglandin-endoperoxide synthase-2/cyclooxygenase 2 (ptgs2/cox-2) colorectal cancer (crc) non-steroidal anti-inflammatory drugs (nsaids) cancer-associated fibroblasts (caf) interleukin-1 beta (il1β) macrophages
Online Erişim:	https://www.mdpi.com/2073-4409/9/3/683
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy

Benzer Materyaller